CN Stock MarketDetailed Quotes

300878 Zhejiang Wecome Pharmaceutical

Watchlist
  • 14.15
  • +0.18+1.29%
Market Closed Jul 26 15:00 CST
2.05BMarket Cap-181410P/E (TTM)

Zhejiang Wecome Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
2.15%199.95M
-2.41%519.62M
-8.93%432M
7.04%316.44M
6.50%195.74M
-15.88%532.44M
-5.40%474.35M
-10.91%295.62M
38.96%183.78M
1.64%632.95M
Operating revenue
2.15%199.95M
-2.41%519.62M
-8.93%432M
7.04%316.44M
6.50%195.74M
-15.88%532.44M
-5.40%474.35M
-10.91%295.62M
38.96%183.78M
1.64%632.95M
Other operating revenue
----
67.09%5.07M
----
12.56%2.25M
----
71.27%3.03M
----
412.42%2M
----
80.63%1.77M
Total operating cost
5.33%173.89M
13.37%560.07M
-5.05%359.42M
7.03%263.85M
1.34%165.1M
-8.16%494.02M
-3.94%378.54M
-5.44%246.51M
51.82%162.92M
10.55%537.89M
Operating cost
-3.83%102.13M
17.66%257.76M
4.36%180.82M
21.95%140.67M
20.12%106.2M
7.19%219.08M
29.03%173.26M
21.38%115.35M
97.42%88.41M
19.23%204.38M
Operating tax surcharges
2,717.77%4.72M
47.68%2.81M
22.67%1.29M
-30.08%680.79K
-79.22%167.57K
-60.27%1.91M
-67.27%1.05M
-51.49%973.65K
423.78%806.59K
38.05%4.8M
Operating expense
30.78%52.34M
7.85%208.19M
-13.44%123.57M
-10.95%83.68M
-29.87%40.02M
-28.50%193.03M
-37.08%142.75M
-35.33%93.97M
4.45%57.06M
0.71%269.99M
Administration expense
25.20%10.77M
9.60%40.94M
3.38%28.65M
6.10%18.77M
-1.88%8.61M
50.93%37.36M
55.69%27.72M
51.42%17.69M
74.84%8.77M
-13.08%24.75M
Financial expense
-24.60%956.97K
127.40%7.56M
-8.11%5.22M
423.19%3.57M
2,018.35%1.27M
209.69%3.33M
253.39%5.69M
126.32%682.06K
104.38%59.92K
42.89%-3.03M
-Interest expense (Financial expense)
-6.59%1.24M
74.69%9.45M
-14.31%6.12M
293.39%4.04M
199.35%1.33M
150.52%5.41M
9,754.63%7.14M
1,316.61%1.03M
513.40%444.24K
752.29%2.16M
-Interest Income (Financial expense)
-43.98%-616.54K
11.97%-1.98M
11.73%-1.4M
19.68%-951.67K
19.84%-428.22K
57.46%-2.25M
62.71%-1.59M
59.30%-1.18M
66.56%-534.24K
5.97%-5.28M
Research and development
-66.40%2.97M
8.84%42.8M
-29.22%19.87M
-7.66%16.48M
13.23%8.84M
6.23%39.32M
80.05%28.07M
92.54%17.85M
90.83%7.81M
81.37%37.02M
Credit Impairment Loss
-4.68%-4.98M
256.85%11.46M
1,308.75%9.27M
605.90%11.14M
-298.51%-4.76M
13.10%-7.31M
107.75%657.82K
118.47%1.58M
231.12%2.4M
-3.69%-8.41M
Asset Impairment Loss
0.00%-34.61K
-232.80%-736.97K
33.45%-125.87K
45.10%-69.22K
45.10%-34.61K
-152.29%-221.44K
---189.13K
---126.09K
---63.04K
---87.77K
Other net revenue
-76.25%569.47K
49.19%39.43M
26.54%21.62M
25.79%21.3M
-55.11%2.4M
547.51%26.43M
493.91%17.08M
540.19%16.93M
521.33%5.34M
-82.11%4.08M
Fair value change income
--2.19M
--4.56M
----
----
----
----
----
----
----
----
Invest income
-79.11%1.25M
-6.22%13.87M
245.71%7.2M
245.71%7.2M
186.02%5.96M
5,494.56%14.79M
--2.08M
--2.08M
--2.08M
--264.33K
-Including: Investment income associates
----
---217.58K
----
----
----
----
----
----
----
----
Asset deal income
---30.53K
99.08%-5.82K
122.88%12.43K
120.83%12.43K
----
-1,038.94%-634.52K
-180.86%-54.33K
-3,067.29%-59.66K
38.93%-1.15K
2,119.45%67.58K
Other revenue
77.11%2.17M
-48.10%10.28M
-63.93%5.26M
-77.62%3.01M
32.60%1.23M
61.72%19.81M
29.17%14.59M
20.22%13.46M
64.99%926.04K
-60.41%12.25M
Operating profit
-19.39%26.63M
-101.56%-1.01M
-16.56%94.2M
11.87%73.89M
26.06%33.04M
-34.59%64.85M
2.41%112.89M
-10.47%66.05M
10.65%26.21M
-37.66%99.14M
Add:Non operating Income
-68.17%35.8K
25.83%518.79K
-88.17%53.56K
-85.40%49.96K
-59.10%112.46K
-59.96%412.29K
-53.84%452.6K
-32.38%342.33K
100.03%274.99K
3.06%1.03M
Less:Non operating expense
-38.69%318.76K
150.33%5.29M
1,022.19%5.16M
95.41%579.28K
184.92%519.93K
1,371.00%2.11M
580.66%459.96K
916.37%296.44K
522.72%182.48K
-89.24%143.69K
Total profit
-19.25%26.35M
-109.16%-5.79M
-21.08%89.09M
11.00%73.36M
24.07%32.63M
-36.87%63.15M
1.56%112.89M
-10.99%66.1M
10.54%26.3M
-36.97%100.03M
Less:Income tax cost
-57.48%1.96M
-97.08%398.59K
-0.15%18.22M
-8.59%7.84M
45.41%4.61M
292.64%13.67M
-0.78%18.24M
-19.87%8.57M
-7.27%3.17M
-84.86%3.48M
Net profit
-12.95%24.39M
SL-6.18M
-25.12%70.87M
13.92%65.53M
21.14%28.02M
-48.75%49.48M
2.02%94.64M
-9.49%57.52M
13.53%23.13M
-28.85%96.55M
Net profit from continuing operation
-12.95%24.39M
-112.50%-6.18M
-25.12%70.87M
13.92%65.53M
21.14%28.02M
-48.75%49.48M
2.02%94.64M
-9.49%57.52M
13.53%23.13M
-28.85%96.55M
Less:Minority Profit
-88.95%54.35K
175.94%1.85M
113.73%1.52M
68.98%904.87K
135.91%491.76K
1,197.89%671.9K
1,387.39%712.44K
344.89%535.5K
110.68%208.45K
146.52%51.77K
Net profit of parent company owners
-11.59%24.33M
-116.47%-8.04M
-26.17%69.35M
13.40%64.62M
20.10%27.53M
-49.42%48.81M
1.31%93.93M
-10.64%56.99M
13.06%22.92M
-28.95%96.5M
Earning per share
Basic earning per share
-10.53%0.17
-117.65%-0.06
-26.16%0.479
13.39%0.4463
-33.31%0.19
-49.25%0.34
-43.72%0.6487
-50.37%0.3936
13.96%0.2849
-67.00%0.67
Diluted earning per share
-10.53%0.17
-117.65%-0.06
-26.16%0.479
13.39%0.4463
-33.31%0.19
-49.25%0.34
-43.72%0.6487
-50.37%0.3936
13.96%0.2849
-67.00%0.67
Other composite income
Total composite income
-12.95%24.39M
-112.50%-6.18M
-25.12%70.87M
13.92%65.53M
21.14%28.02M
-48.75%49.48M
2.02%94.64M
-9.49%57.52M
13.53%23.13M
-28.85%96.55M
Total composite income of parent company owners
-11.59%24.33M
-116.47%-8.04M
-26.17%69.35M
13.40%64.62M
20.10%27.53M
-49.42%48.81M
1.31%93.93M
-10.64%56.99M
13.06%22.92M
-28.95%96.5M
Total composite income of minority owners
-88.95%54.35K
175.94%1.85M
113.73%1.52M
68.98%904.87K
135.91%491.76K
1,197.89%671.9K
1,387.39%712.44K
344.89%535.5K
110.68%208.45K
146.52%51.77K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Reservations with explanatory notes
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue 2.15%199.95M-2.41%519.62M-8.93%432M7.04%316.44M6.50%195.74M-15.88%532.44M-5.40%474.35M-10.91%295.62M38.96%183.78M1.64%632.95M
Operating revenue 2.15%199.95M-2.41%519.62M-8.93%432M7.04%316.44M6.50%195.74M-15.88%532.44M-5.40%474.35M-10.91%295.62M38.96%183.78M1.64%632.95M
Other operating revenue ----67.09%5.07M----12.56%2.25M----71.27%3.03M----412.42%2M----80.63%1.77M
Total operating cost 5.33%173.89M13.37%560.07M-5.05%359.42M7.03%263.85M1.34%165.1M-8.16%494.02M-3.94%378.54M-5.44%246.51M51.82%162.92M10.55%537.89M
Operating cost -3.83%102.13M17.66%257.76M4.36%180.82M21.95%140.67M20.12%106.2M7.19%219.08M29.03%173.26M21.38%115.35M97.42%88.41M19.23%204.38M
Operating tax surcharges 2,717.77%4.72M47.68%2.81M22.67%1.29M-30.08%680.79K-79.22%167.57K-60.27%1.91M-67.27%1.05M-51.49%973.65K423.78%806.59K38.05%4.8M
Operating expense 30.78%52.34M7.85%208.19M-13.44%123.57M-10.95%83.68M-29.87%40.02M-28.50%193.03M-37.08%142.75M-35.33%93.97M4.45%57.06M0.71%269.99M
Administration expense 25.20%10.77M9.60%40.94M3.38%28.65M6.10%18.77M-1.88%8.61M50.93%37.36M55.69%27.72M51.42%17.69M74.84%8.77M-13.08%24.75M
Financial expense -24.60%956.97K127.40%7.56M-8.11%5.22M423.19%3.57M2,018.35%1.27M209.69%3.33M253.39%5.69M126.32%682.06K104.38%59.92K42.89%-3.03M
-Interest expense (Financial expense) -6.59%1.24M74.69%9.45M-14.31%6.12M293.39%4.04M199.35%1.33M150.52%5.41M9,754.63%7.14M1,316.61%1.03M513.40%444.24K752.29%2.16M
-Interest Income (Financial expense) -43.98%-616.54K11.97%-1.98M11.73%-1.4M19.68%-951.67K19.84%-428.22K57.46%-2.25M62.71%-1.59M59.30%-1.18M66.56%-534.24K5.97%-5.28M
Research and development -66.40%2.97M8.84%42.8M-29.22%19.87M-7.66%16.48M13.23%8.84M6.23%39.32M80.05%28.07M92.54%17.85M90.83%7.81M81.37%37.02M
Credit Impairment Loss -4.68%-4.98M256.85%11.46M1,308.75%9.27M605.90%11.14M-298.51%-4.76M13.10%-7.31M107.75%657.82K118.47%1.58M231.12%2.4M-3.69%-8.41M
Asset Impairment Loss 0.00%-34.61K-232.80%-736.97K33.45%-125.87K45.10%-69.22K45.10%-34.61K-152.29%-221.44K---189.13K---126.09K---63.04K---87.77K
Other net revenue -76.25%569.47K49.19%39.43M26.54%21.62M25.79%21.3M-55.11%2.4M547.51%26.43M493.91%17.08M540.19%16.93M521.33%5.34M-82.11%4.08M
Fair value change income --2.19M--4.56M--------------------------------
Invest income -79.11%1.25M-6.22%13.87M245.71%7.2M245.71%7.2M186.02%5.96M5,494.56%14.79M--2.08M--2.08M--2.08M--264.33K
-Including: Investment income associates -------217.58K--------------------------------
Asset deal income ---30.53K99.08%-5.82K122.88%12.43K120.83%12.43K-----1,038.94%-634.52K-180.86%-54.33K-3,067.29%-59.66K38.93%-1.15K2,119.45%67.58K
Other revenue 77.11%2.17M-48.10%10.28M-63.93%5.26M-77.62%3.01M32.60%1.23M61.72%19.81M29.17%14.59M20.22%13.46M64.99%926.04K-60.41%12.25M
Operating profit -19.39%26.63M-101.56%-1.01M-16.56%94.2M11.87%73.89M26.06%33.04M-34.59%64.85M2.41%112.89M-10.47%66.05M10.65%26.21M-37.66%99.14M
Add:Non operating Income -68.17%35.8K25.83%518.79K-88.17%53.56K-85.40%49.96K-59.10%112.46K-59.96%412.29K-53.84%452.6K-32.38%342.33K100.03%274.99K3.06%1.03M
Less:Non operating expense -38.69%318.76K150.33%5.29M1,022.19%5.16M95.41%579.28K184.92%519.93K1,371.00%2.11M580.66%459.96K916.37%296.44K522.72%182.48K-89.24%143.69K
Total profit -19.25%26.35M-109.16%-5.79M-21.08%89.09M11.00%73.36M24.07%32.63M-36.87%63.15M1.56%112.89M-10.99%66.1M10.54%26.3M-36.97%100.03M
Less:Income tax cost -57.48%1.96M-97.08%398.59K-0.15%18.22M-8.59%7.84M45.41%4.61M292.64%13.67M-0.78%18.24M-19.87%8.57M-7.27%3.17M-84.86%3.48M
Net profit -12.95%24.39MSL-6.18M-25.12%70.87M13.92%65.53M21.14%28.02M-48.75%49.48M2.02%94.64M-9.49%57.52M13.53%23.13M-28.85%96.55M
Net profit from continuing operation -12.95%24.39M-112.50%-6.18M-25.12%70.87M13.92%65.53M21.14%28.02M-48.75%49.48M2.02%94.64M-9.49%57.52M13.53%23.13M-28.85%96.55M
Less:Minority Profit -88.95%54.35K175.94%1.85M113.73%1.52M68.98%904.87K135.91%491.76K1,197.89%671.9K1,387.39%712.44K344.89%535.5K110.68%208.45K146.52%51.77K
Net profit of parent company owners -11.59%24.33M-116.47%-8.04M-26.17%69.35M13.40%64.62M20.10%27.53M-49.42%48.81M1.31%93.93M-10.64%56.99M13.06%22.92M-28.95%96.5M
Earning per share
Basic earning per share -10.53%0.17-117.65%-0.06-26.16%0.47913.39%0.4463-33.31%0.19-49.25%0.34-43.72%0.6487-50.37%0.393613.96%0.2849-67.00%0.67
Diluted earning per share -10.53%0.17-117.65%-0.06-26.16%0.47913.39%0.4463-33.31%0.19-49.25%0.34-43.72%0.6487-50.37%0.393613.96%0.2849-67.00%0.67
Other composite income
Total composite income -12.95%24.39M-112.50%-6.18M-25.12%70.87M13.92%65.53M21.14%28.02M-48.75%49.48M2.02%94.64M-9.49%57.52M13.53%23.13M-28.85%96.55M
Total composite income of parent company owners -11.59%24.33M-116.47%-8.04M-26.17%69.35M13.40%64.62M20.10%27.53M-49.42%48.81M1.31%93.93M-10.64%56.99M13.06%22.92M-28.95%96.5M
Total composite income of minority owners -88.95%54.35K175.94%1.85M113.73%1.52M68.98%904.87K135.91%491.76K1,197.89%671.9K1,387.39%712.44K344.89%535.5K110.68%208.45K146.52%51.77K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Reservations with explanatory notes------Unqualified opinion------Unqualified opinion
Auditor --Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg